{
    "clinical_study": {
        "@rank": "21676", 
        "arm_group": [
            {
                "arm_group_label": "Cupping therapy (randomized)", 
                "arm_group_type": "Experimental", 
                "description": "Use retained cupping as the main cupping method, supplemented with flash cupping and/or moving cupping. First use empty cupping, which means the cups are removed after suction without delay, then practitioners should control the suction by gently moving the cup toward direction of DU and/or BL, repeat this moving for several times, finally cupping practitioners utilize the flaming heating power to achieve suction (minus pressure) inside the cups to make them apply on the desired part of the body. Cups should retain for 10 minutes daily, patients accept the treatment three times weekly for totally 15 times."
            }, 
            {
                "arm_group_label": "Cupping therapy (non-randomized)", 
                "arm_group_type": "Experimental", 
                "description": "Use retained cupping as the main cupping method, supplemented with flash cupping and/or moving cupping. First use empty cupping, which means the cups are removed after suction without delay, then practitioners should control the suction by gently moving the cup toward direction of DU and/or BL, repeat this moving for several times, finally cupping practitioners utilize the flaming heating power to achieve suction (minus pressure) inside the cups to make them apply on the desired part of the body. Cups should retain for 10 minutes daily, patients accept the treatment three times weekly for totally 15 times."
            }, 
            {
                "arm_group_label": "Acupuncture (non-randomized)", 
                "arm_group_type": "Active Comparator", 
                "description": "Sterilize the selected points with alcohol, and then select the specific size of needles to do the acupuncture. Do the manual stimulation for seconds after needles' insertion, including twist, pull up and deeper insert. Needles should be withdrawn after 30 minutes. Patients accept the treatment three times weekly for totally 15 times."
            }, 
            {
                "arm_group_label": "Acupuncture (randomized)", 
                "arm_group_type": "Active Comparator", 
                "description": "Sterilize the selected points with alcohol, and then select the specific size of needles to do the acupuncture. Do the manual stimulation for seconds after needles' insertion, including twist, pull up and deeper insert. Needles should be withdrawn after 30 minutes."
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the application of partially randomized patient preference (PRPP) trial model\n      which concerns the patients' preference on evaluation the therapeutic effect of\n      non-pharmaceutical therapy, and to observe the therapeutic effect of two kinds of\n      non-pharmaceutical therapies (acupuncture and cupping therapy) for fibromyalgia."
        }, 
        "brief_title": "PRPP Model for Evaluation the Effect of Non-pharmaceutical Therapies", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Fibromyalgia", 
        "condition_browse": {
            "mesh_term": [
                "Fibromyalgia", 
                "Myofascial Pain Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with fibromyalgia diagnosed according to criteria formulated by American\n             College Rheumatology 2002;\n\n          -  Patients whose scores for pain intensity is more than 30mm;\n\n          -  Patients who are 20 to 60 years old;\n\n          -  Patients who fully understand the process of this research and who are willing to\n             provide informed consent.\n\n        Exclusion Criteria:\n\n          -  The widespread muscular-skeletal pain is caused by some kind of disease, surgery, or\n             other external interference factors (except fibromyalgia);\n\n          -  Patients with mental disorders, or other serious organic diseases, such as organ\n             failure;\n\n          -  Patients who take oral anodyne medications or accept other interventions for pain\n             relief during the treatment;\n\n          -  Pregnant or lactating women;\n\n          -  Patients currently participating in another clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01869712", 
            "org_study_id": "0100604024"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Cupping therapy (randomized)", 
                    "Cupping therapy (non-randomized)"
                ], 
                "intervention_name": "Cupping therapy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Acupuncture (non-randomized)", 
                    "Acupuncture (randomized)"
                ], 
                "intervention_name": "Acupuncture", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "cupping therapy", 
            "acupuncture", 
            "partially randomized", 
            "patient preference", 
            "fibromyalgia", 
            "criteria formulated by American College Rheumatology 2002"
        ], 
        "lastchanged_date": "October 15, 2013", 
        "location": {
            "contact": {
                "email": "huhui65@163.com", 
                "last_name": "Hui Hu, Ph.D.", 
                "phone": "+86 10 67689713"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100078"
                }, 
                "name": "Beijing University of Chinese Medicine Affiliated Dongfang Hospital"
            }, 
            "investigator": {
                "last_name": "Hui Hu, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Using Partially Randomized Patient Preference Research Model for Evaluation the Therapeutic Effect of Non-pharmaceutical Therapies: Protocol for a Feasibility Study", 
        "other_outcome": [
            {
                "description": "WPI is defined according to the American College of Rheumatology diagnostic criteria \uff082002\uff09for fibromyalgia.", 
                "measure": "Widespread Pain Index (WPI\uff09for pain intensity", 
                "safety_issue": "No", 
                "time_frame": "WPI should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively."
            }, 
            {
                "description": "SS is defined according to the American College of Rheumatology diagnostic criteria \uff082002\uff09for fibromyalgia", 
                "measure": "Symptom Severity (SS) for pain intensity", 
                "safety_issue": "No", 
                "time_frame": "SS should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively."
            }, 
            {
                "measure": "Hamilton Depression Scale (HAMD)", 
                "safety_issue": "No", 
                "time_frame": "HAMD is measured totally 3 times at week 0, week 5 and week 17, respectively."
            }, 
            {
                "measure": "Quality of life measured by The Medical Outcome Study 36-item short-form health survey (SF36)", 
                "safety_issue": "No", 
                "time_frame": "SF36 is measured totally 3 times at week 0, week 5 and week 17, respectively."
            }, 
            {
                "measure": "Fibromyalgia Intensive Questionnaire (FIQ)", 
                "safety_issue": "No", 
                "time_frame": "FIQ is measured totally 3 times at week 0, week 5 and week 17, respectively."
            }
        ], 
        "overall_contact": {
            "email": "huijuancao327@hotmail.com", 
            "last_name": "Huijuan Cao, Ph.D.", 
            "phone": "+86 10 64286757"
        }, 
        "overall_contact_backup": {
            "email": "jianping_l@hotmail.com", 
            "last_name": "Jianping Liu, Ph.D.", 
            "phone": "+86 10 64286760"
        }, 
        "overall_official": {
            "affiliation": "Beijing University of Chinese Medicine", 
            "last_name": "Huijuan Cao, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: State Administration of Traditional Chinese Medicine of the People's Republic of China", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Patients' compliance", 
                "safety_issue": "No", 
                "time_frame": "Record the number of drop out or lost during the 5 weeks' treatment and 3 months' follow up duration (for an expected totally 17 weeks) and note the reason for missing data"
            }, 
            {
                "description": "Satisfactory for the treatment is measured by a seven-score scale, with 1 for \"very satisfied\" and 7 for \"very unsatisfied\".", 
                "measure": "Patients satisfactory for the treatment", 
                "safety_issue": "No", 
                "time_frame": "The satisfactory for the treatment is investigated at week 5 (as the end of the treatment)."
            }, 
            {
                "description": "Individual interview or the focus group interview will be applied after the treatment, all the practitioners in the study (including acupuncturists and cupping therapy practitioners) will be interviewed to know their attitude for conducting the partially randomized patient preference trial model and their thoughts of this model compare to general randomized controlled trial.", 
                "measure": "Practitioners' attitude for the research model", 
                "safety_issue": "No", 
                "time_frame": "Practitioners' attitude for the research model is investigated at week 5 (as the end of the treatment)."
            }
        ], 
        "reference": [
            {
                "PMID": "21701180", 
                "citation": "Cao H, Hu H, Colagiuri B, Liu J. Medicinal cupping therapy in 30 patients with fibromyalgia: a case series observation. Forsch Komplementmed. 2011;18(3):122-6. doi: 10.1159/000329329. Epub 2011 May 24."
            }, 
            {
                "PMID": "20423209", 
                "citation": "Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010 Apr;16(4):397-409. doi: 10.1089/acm.2009.0599. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01869712"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing University of Chinese Medicine", 
            "investigator_full_name": "Huijuan Cao", 
            "investigator_title": "Research Associate", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Researchers should note any minor or serious adverse event occurs during treatment and follow up duration, including cases and symptoms of patients with adverse events.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Adverse events will be observed for the duration of 5 weeks' treatment and 3 months' follow-up, with an expected average of totally 17 weeks."
            }, 
            {
                "description": "Patients' expectation is measured by a four-score scale, with 1 for \"symptoms are totally disappear\" and 4 for \"no change for symptoms\".", 
                "measure": "Patients' expectation for the treatment", 
                "safety_issue": "No", 
                "time_frame": "Patients' expectation is investigated at week 0"
            }, 
            {
                "description": "The length of scale of VAS is 100mm, 0 is representing for no pain, and 100 is representing unbearable pain which may affect appetite and quality of sleep. Researchers should show the scale to patients, and note the scores of pain degree given by patients according to the scale.", 
                "measure": "Visual Analogue Scale (VAS) for pain intensity", 
                "safety_issue": "No", 
                "time_frame": "VAS should be measured seven times at week 0, the end of each five times treatment (totally fifteen times treatment in 5 weeks), week 9, week 13, and week 17, respectively."
            }
        ], 
        "source": "Beijing University of Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing University of Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}